Skip to main content
Clinical Trials/NCT01713933
NCT01713933
Completed
Not Applicable

Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Brachia

Ulthera, Inc1 site in 1 country37 target enrollmentJune 2011
ConditionsBrachial Ptosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brachial Ptosis
Sponsor
Ulthera, Inc
Enrollment
37
Locations
1
Primary Endpoint
Improvement in Obtaining Lift and Tightening of Brachial Skin Laxity
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study is an evaluation of the Ulthera® System used to treat the upper arms for improvement of brachial ptosis. All enrolled subjects will receive one bilateral upper arm treatment. Follow-up visits will occur at 60, 90 and 180 days post-treatment.

Detailed Description

This is a prospective, non-randomized, clinical trial treating up to 35 subjects. Study photographs of the upper arms will be taken prior to treatment, immediately post-treatment, and at each follow-up visit. Brachial volume and dermal thickness measurements will be obtained.

Registry
clinicaltrials.gov
Start Date
June 2011
End Date
May 2012
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female, aged 19 - 55 years.
  • Subject in good health.
  • Subjects who desire lift and tightening of the brachia and improvement in skin laxity.
  • Mild to moderate laxity of the upper arm.
  • Mild to moderate subcutaneous fat of the upper arm.
  • Mild crepiness of the skin of the upper arm.
  • Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.
  • Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.

Exclusion Criteria

  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Severe solar elastosis.
  • Excessive subcutaneous fat in the upper arm.
  • Excessive skin laxity in the upper arm.
  • Significant scarring in areas to be treated.
  • Significant open wounds or lesions in the treatment areas.
  • Severe or cystic acne in the treatment areas.

Outcomes

Primary Outcomes

Improvement in Obtaining Lift and Tightening of Brachial Skin Laxity

Time Frame: Baseline to 90 days post-treatment

Improvement in overall lifting and tightening of brachial skin laxity as determined by masked, qualitative assessment of photographs at 90 days post-treatment compared to baseline.

Secondary Outcomes

  • Change in Dermal Thickness(Baseline to180 days post-treatment)
  • Overall Aesthetic Improvement(Baseline to180 days post-treatment)
  • Patient Satisfaction(Baseline to 180 days post-treatment)
  • Quantitative Improvement in Skin Laxity(Baseline to 90 days post-treatment)

Study Sites (1)

Loading locations...

Similar Trials